BioMinds LifeSciences announces the release of PathoOligoDB(TM), a free qPCR oligos for pathogen.

PRLog (Press Release) - Oct 21, 2007 -
BioMinds LifeSciences Pvt Ltd., Hyderabad, India,  today announced the release of one of its pioneering products for researchers working on pathogen detection using qPCR in laboratories around the globe.

PathoOligoDB^TM is an extensive and carefully curated database containing a wide array of information on pathogen detection using the widely applied qPCR technique. The product is absolutely free for academic use and currently holds curated information of bacterial, fungal and viral pathogens. As of now, PathoOligoDB^TMcontains about 2978 specific oligos for 1023 pathogenic genes reported in about 150 pathogenic organisms, 1200 specific sample information and 1455 enzymes from about 35 journals. Besides this, researchers will also find extensive information on relevant experimental recipes such as buffers, other chemicals and reagents, and relevant vendor information for the resources mentioned.

PathoOligoDB^TM is equipped with an innovative algorithm to quickly search for the oligos and related resources based on search filtering specified by the user. Users can search for oligos using the pathogen name, gene symbol, assay application, oligo sequence information, PubMed ID, oligo design vendors, and types of popular detection chemistries such as: TaqMan®, TaqMan MGB, Molecular Beacon, SYBR® Green, LNA®, and FRET etc.

The other couple of databases and desktop software products are in the pipeline to serve the life science informatics researchers needs. For more information about BioMinds products please visit:  http://www.biominds.org.in/Prod_Overview.html

"According to ABRF 2007 Nucleic Acid Research Group Survey”, qPCR is the third most opted pathogen detection approach among researchers around the world. We have designed PathoOligoDBTM after understanding the importance and the demand for instant information on optimized oligos, which would save the valuable time and cost involved in manual designing of oligos.”, says Dr. Ravi Kumar, Director of BioMinds LifeSciences Pvt Ltd. He invites the researchers to submit the validated oligos data to further strengthen the database and make it available for the research community.
Learn more about  PathoOligoDB^TM at : www.pathooligodb.com

The researchers laboratories/ diagnostic labs/funding agencies are also invited  for their valuable contribution and promote the only database of this kind. For more details write to ravi@biominds.org.in